Plus Therapeutics (PSTV) Q1 2026 Earnings

12MarConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-1.19
-0.79
-0.38
0.02

Details

Expected EPS
-0.8
Actual EPS
-0.833575
Surprise EPS
-0.03
Surprise Percent
+4.2%

Description

Plus Therapeutics (PSTV) has reported earnings of -0.833575 per share for Q1 2026.

0 Comments

Share your thoughts